The NF-κB signalling pathway is one of the core pathways of the pathogenesis of sepsis, and the development of drugs to interfere with the NF-κB signalling pathway is considered to be a key method to reduce the mortality of sepsis (Cai et al. Here, NFKB1 is linked to Sepsis.